Rationale for targeting complement in COVID‐19
Abstract A novel coronavirus, SARS‐CoV‐2, has recently emerged in China and spread internationally, posing a health emergency to the global community. COVID‐19 caused by SARS‐CoV‐2 is associated with an acute respiratory illness that varies from mild to the life‐threatening acute respiratory distres...
Saved in:
| Main Authors: | Anastasia Polycarpou, Mark Howard, Conrad A Farrar, Roseanna Greenlaw, Giorgia Fanelli, Russell Wallis, Linda S Klavinskis, Steven Sacks |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2020-07-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.202012642 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COFUNCTIONING OF PROTECTIVE SYSTEMS: MUCOSAL IMMUNITY AND HUMAN COMPLEMENT SYSTEM
by: M. V. Lakhtin, et al.
Published: (2015-09-01) -
DYSFUNCTION OF COMPLEMENT SYSTEM IN FAMILIAL MEDITERRANEAN FEVER
by: G. M. Mkrtchyan, et al.
Published: (2014-07-01) -
Identification of SARS-CoV-2-binding lectins on a commercial lectin array
by: Neetu, et al.
Published: (2025-07-01) -
Nanobody‐mediated complement activation to kill HIV‐infected cells
by: Maria Lange Pedersen, et al.
Published: (2023-02-01) -
Gut microbial dysbiosis activates the classical complement pathway in a short-term morphine treatment model
by: Nicolas Vitari, et al.
Published: (2025-12-01)